These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 25720817

  • 21. Biorelevant Drug Solubility Enhancement Modeled by a Linear Solvation Energy Relationship.
    Niederquell A, Kuentz M.
    J Pharm Sci; 2018 Jan; 107(1):503-506. PubMed ID: 28864357
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E, Westergren J, Grant I, Hanisch G, Lindfors L, Lennernäs H, Abrahamsson B, Tannergren C.
    Eur J Pharm Sci; 2013 Jul 16; 49(4):679-98. PubMed ID: 23727464
    [Abstract] [Full Text] [Related]

  • 24. Molecular interactions between lecithin and bile salts/acids in oils and their effects on reverse micellization.
    Njauw CW, Cheng CY, Ivanov VA, Khokhlov AR, Tung SH.
    Langmuir; 2013 Mar 26; 29(12):3879-88. PubMed ID: 23441904
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Interactions between biliary lipid micelles and intestinal brush border membranes investigated by 1H and 31P nuclear magnetic resonance.
    Tellier C, Vallet-Strouve C, Akoka S, Poignant S.
    Eur Biophys J; 1987 Mar 26; 15(3):177-84. PubMed ID: 3443080
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Structural mechanisms of bile salt-induced growth of small unilamellar cholesterol-lecithin vesicles.
    Luk AS, Kaler EW, Lee SP.
    Biochemistry; 1997 May 13; 36(19):5633-44. PubMed ID: 9153403
    [Abstract] [Full Text] [Related]

  • 29. Predicting biopharmaceutical performance of oral drug candidates - Extending the volume to dissolve applied dose concept.
    Muenster U, Mueck W, van der Mey D, Schlemmer KH, Greschat-Schade S, Haerter M, Pelzetter C, Pruemper C, Verlage J, Göller AH, Ohm A.
    Eur J Pharm Biopharm; 2016 May 13; 102():191-201. PubMed ID: 26955751
    [Abstract] [Full Text] [Related]

  • 30. Cholesterol enhances membrane-damaging properties of model bile by increasing the intervesicular-intermixed micellar concentration of hydrophobic bile salts.
    Narain PK, DeMaria EJ, Heuman DM.
    J Surg Res; 1999 Jun 01; 84(1):112-9. PubMed ID: 10334899
    [Abstract] [Full Text] [Related]

  • 31. Enlargement of taurocholate micelles by added cholesterol and monoolein: self-diffusion measurements.
    Woodford FP.
    J Lipid Res; 1969 Sep 01; 10(5):539-45. PubMed ID: 5808827
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Behavior of cholesterol and spin-labeled cholestane in model bile systems studied by electron spin resonance and synchrotron x-ray.
    Sömjen GJ, Lipka G, Schulthess G, Koch MH, Wachtel E, Gilat T, Hauser H.
    Biophys J; 1995 Jun 01; 68(6):2342-9. PubMed ID: 7647238
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Solvent-mediated solid phase transformations of carbamazepine: Effects of simulated intestinal fluid and fasted state simulated intestinal fluid.
    Lehto P, Aaltonen J, Tenho M, Rantanen J, Hirvonen J, Tanninen VP, Peltonen L.
    J Pharm Sci; 2009 Mar 01; 98(3):985-96. PubMed ID: 18661533
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Impact of FaSSIF on the solubility and dissolution-/permeation rate of a poorly water-soluble compound.
    Frank KJ, Westedt U, Rosenblatt KM, Hölig P, Rosenberg J, Mägerlein M, Brandl M, Fricker G.
    Eur J Pharm Sci; 2012 Aug 30; 47(1):16-20. PubMed ID: 22579958
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.